Cargando…
Rituximab for Anti–Glomerular Basement Membrane Disease
Autores principales: | Jain, Rashmi, Dgheim, Hanna, Bomback, Andrew S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451084/ https://www.ncbi.nlm.nih.gov/pubmed/30993238 http://dx.doi.org/10.1016/j.ekir.2018.12.002 |
Ejemplares similares
-
Reversal of Dialysis-Dependent Anti–Glomerular Basement Membrane Disease Using Plasma Exchange, Glucocorticosteroids, and Rituximab
por: Lemahieu, Wim, et al.
Publicado: (2018) -
Binding Truths: Seronegative Anti-Glomerular Basement Membrane Disease Mediated by IgM Anti-Glomerular Basement Membrane Antibodies
por: Antonelou, Marilina, et al.
Publicado: (2023) -
Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease
por: Nithagon, Pravarut, et al.
Publicado: (2021) -
Binding Truths: Atypical Anti−Glomerular Basement Membrane Disease Mediated by IgA Anti−Glomerular Basement Membrane Antibodies Targeting the α1 Chain of Type IV Collagen
por: Antonelou, Marilina, et al.
Publicado: (2018) -
A Case of Glomerulopathy Associated With Monoclonal Glomerular Basement Membrane Antibody
por: Bonilla, Marco, et al.
Publicado: (2021)